Ad is loading...
LZAGY
Price
$58.66
Change
-$0.00 (-0.00%)
Updated
Nov 21 closing price
64 days until earnings call
PROF
Price
$7.52
Change
-$0.17 (-2.21%)
Updated
Nov 21 closing price
109 days until earnings call
Ad is loading...

LZAGY vs PROF

Header iconLZAGY vs PROF Comparison
Open Charts LZAGY vs PROFBanner chart's image
Lonza Group AG
Price$58.66
Change-$0.00 (-0.00%)
Volume$831.85K
CapitalizationN/A
Profound Medical
Price$7.52
Change-$0.17 (-2.21%)
Volume$23.15K
CapitalizationN/A
LZAGY vs PROF Comparison Chart
Loading...
LZAGY
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
PROF
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
LZAGY vs. PROF commentary
Nov 22, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LZAGY is a Buy and PROF is a Hold.

COMPARISON
Comparison
Nov 22, 2024
Stock price -- (LZAGY: $58.66 vs. PROF: $7.52)
Brand notoriety: LZAGY and PROF are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: LZAGY: 1331% vs. PROF: 46%
Market capitalization -- LZAGY: $43.14B vs. PROF: $205.33M
LZAGY [@Medical Specialties] is valued at $43.14B. PROF’s [@Medical Specialties] market capitalization is $205.33M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.03B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LZAGY’s FA Score shows that 1 FA rating(s) are green whilePROF’s FA Score has 0 green FA rating(s).

  • LZAGY’s FA Score: 1 green, 4 red.
  • PROF’s FA Score: 0 green, 5 red.
According to our system of comparison, LZAGY is a better buy in the long-term than PROF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LZAGY’s TA Score shows that 4 TA indicator(s) are bullish while PROF’s TA Score has 3 bullish TA indicator(s).

  • LZAGY’s TA Score: 4 bullish, 5 bearish.
  • PROF’s TA Score: 3 bullish, 7 bearish.
According to our system of comparison, LZAGY is a better buy in the short-term than PROF.

Price Growth

LZAGY (@Medical Specialties) experienced а -5.80% price change this week, while PROF (@Medical Specialties) price change was -6.13% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +3.21%. For the same industry, the average monthly price growth was +0.99%, and the average quarterly price growth was -2.23%.

Reported Earning Dates

LZAGY is expected to report earnings on Jan 25, 2025.

PROF is expected to report earnings on Mar 11, 2025.

Industries' Descriptions

@Medical Specialties (+3.21% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LZAGY($43.1B) has a higher market cap than PROF($205M). LZAGY YTD gains are higher at: 40.467 vs. PROF (-11.425). LZAGY has higher annual earnings (EBITDA): 1.42B vs. PROF (-26.78M). LZAGY has more cash in the bank: 2.15B vs. PROF (26.2M). PROF has less debt than LZAGY: PROF (7.94M) vs LZAGY (2.91B). LZAGY has higher revenues than PROF: LZAGY (6.32B) vs PROF (7.2M).
LZAGYPROFLZAGY / PROF
Capitalization43.1B205M21,024%
EBITDA1.42B-26.78M-5,287%
Gain YTD40.467-11.425-354%
P/E Ratio32.68N/A-
Revenue6.32B7.2M87,776%
Total Cash2.15B26.2M8,198%
Total Debt2.91B7.94M36,645%
FUNDAMENTALS RATINGS
LZAGY vs PROF: Fundamental Ratings
LZAGY
PROF
OUTLOOK RATING
1..100
7670
VALUATION
overvalued / fair valued / undervalued
1..100
20
Undervalued
50
Fair valued
PROFIT vs RISK RATING
1..100
57100
SMR RATING
1..100
9298
PRICE GROWTH RATING
1..100
5461
P/E GROWTH RATING
1..100
58100
SEASONALITY SCORE
1..100
n/a85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

LZAGY's Valuation (20) in the null industry is in the same range as PROF (50). This means that LZAGY’s stock grew similarly to PROF’s over the last 12 months.

LZAGY's Profit vs Risk Rating (57) in the null industry is somewhat better than the same rating for PROF (100). This means that LZAGY’s stock grew somewhat faster than PROF’s over the last 12 months.

LZAGY's SMR Rating (92) in the null industry is in the same range as PROF (98). This means that LZAGY’s stock grew similarly to PROF’s over the last 12 months.

LZAGY's Price Growth Rating (54) in the null industry is in the same range as PROF (61). This means that LZAGY’s stock grew similarly to PROF’s over the last 12 months.

LZAGY's P/E Growth Rating (58) in the null industry is somewhat better than the same rating for PROF (100). This means that LZAGY’s stock grew somewhat faster than PROF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
LZAGYPROF
RSI
ODDS (%)
Bullish Trend 2 days ago
70%
Bearish Trend 2 days ago
77%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
76%
Momentum
ODDS (%)
Bearish Trend 2 days ago
54%
Bearish Trend 2 days ago
83%
MACD
ODDS (%)
Bearish Trend 2 days ago
58%
Bearish Trend 2 days ago
76%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
58%
Bearish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
59%
Bullish Trend 2 days ago
79%
Advances
ODDS (%)
Bullish Trend 2 days ago
60%
Bullish Trend 16 days ago
78%
Declines
ODDS (%)
Bearish Trend 5 days ago
53%
Bearish Trend 2 days ago
79%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
65%
Bearish Trend 2 days ago
82%
Aroon
ODDS (%)
Bearish Trend 2 days ago
60%
Bearish Trend 2 days ago
83%
View a ticker or compare two or three
Ad is loading...
LZAGY
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
PROF
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ZVNIX39.970.60
+1.52%
Zevenbergen Growth Institutional
JMCEX66.430.94
+1.44%
JPMorgan Mid Cap Equity R2
BDAUX28.480.14
+0.49%
Baron Durable Advantage R6
BMCRX27.57N/A
N/A
BlackRock Advantage Large Cap Gr R
EMOLX16.04-0.05
-0.31%
Lord Abbett Emerging Markets Equity F3

LZAGY and

Correlation & Price change

A.I.dvisor indicates that over the last year, LZAGY has been loosely correlated with LZAGF. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if LZAGY jumps, then LZAGF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LZAGY
1D Price
Change %
LZAGY100%
+0.12%
LZAGF - LZAGY
62%
Loosely correlated
+0.34%
TMO - LZAGY
42%
Loosely correlated
+0.64%
SOAGY - LZAGY
41%
Loosely correlated
+0.44%
CRL - LZAGY
37%
Loosely correlated
+3.35%
TRXO - LZAGY
36%
Loosely correlated
N/A
More

PROF and

Correlation & Price change

A.I.dvisor tells us that PROF and ALC have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PROF and ALC's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PROF
1D Price
Change %
PROF100%
-2.21%
ALC - PROF
30%
Poorly correlated
+0.08%
LZAGY - PROF
29%
Poorly correlated
+0.12%
GH - PROF
27%
Poorly correlated
+0.98%
VCYT - PROF
24%
Poorly correlated
-0.66%
RDNT - PROF
24%
Poorly correlated
-1.05%
More